Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 101 for

Edit search filters
  1. A Study To See If Memantine Protects The Brain During Radiation Therapy Treatment For A Brain Tumor

    Rochester, MN

  2. Innovative Trial For Understanding The Impact Of Targeted Therapies In NF2

    Rochester, MN

  3. A Study of Fluorine F 18 Fluorodopa-Labeled PET Scans for Planning Surgery and Radiation Therapy to Treat Patients who have Newly Diagnosed High- or Low-Grade Glioma Brain Cancer Tumors

    Rochester, MN

  4. FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

    Rochester, MN

  5. A Study Testing The Effect Of Immunotherapy (Ipilimumab And Nivolumab) In Patients With Recurrent Glioblastoma With Elevated Mutational Burden

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Rochester, MN

  6. A Study To Evaluate CB-839 With Radiation Therapy And Temozolomide In Treating Participants With IDH-Mutated Diffuse Astrocytoma Or Anaplastic Astrocytoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Phase 1/2 Study Of Silevertinib (BDTX-1535) In Patients With Glioblastoma Or Non-Small Cell Lung Cancer With EGFR Mutations

    Jacksonville, FL, Rochester, MN

  8. Feasibility Study Comparing the Utility of GLOW800 and FL800 Intraoperative ICG-VA Tools for Intracranial Lesions

    Scottsdale/Phoenix, AZ

  9. A Study Comparing Abemaciclib Plus Temozolomide To Temozolomide Monotherapy In Children And Young Adults With High-grade Glioma Following Radiotherapy

    Rochester, MN

  10. Radiation Therapy With Or Without Temozolomide In Treating Patients With Anaplastic Glioma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer